Ad
PSTV Quote Trading Chart PLUS THERAPEUTICS Inc.
home / stock / pstv / pstv quote
Quote | PLUS THERAPEUTICS Inc. (NASDAQ:PSTV)
| Last: | $1.37 |
|---|---|
| Change Percent: | -3.14% |
| Open: | $1.3408 |
| Close: | $1.37 |
| High: | $1.395 |
| Low: | $1.31 |
| Volume: | 11,441 |
| Last Trade Date Time: | 10/11/2024 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
PSTV Last Twenty Trading Days
| Last | Open | Close | High | Low | Volume | Date |
|---|---|---|---|---|---|---|
| $1.37 | $1.3408 | $1.37 | $1.395 | $1.31 | 11,441 | 10-11-2024 |
| $1.3 | $1.3159 | $1.3 | $1.32 | $1.2799 | 23,315 | 10-10-2024 |
| $1.36 | $1.35 | $1.36 | $1.3899 | $1.31 | 8,978 | 10-09-2024 |
| $1.35 | $1.38 | $1.35 | $1.41 | $1.3201 | 47,971 | 10-08-2024 |
| $1.41 | $1.39 | $1.41 | $1.5 | $1.3001 | 51,160 | 10-07-2024 |
| $1.3 | $1.33 | $1.3 | $1.3397 | $1.28 | 42,952 | 10-04-2024 |
| $1.3032 | $1.46 | $1.3032 | $1.46 | $1.21 | 134,370 | 10-03-2024 |
| $1.41 | $1.34 | $1.41 | $1.46 | $1.3257 | 53,745 | 10-02-2024 |
| $1.31 | $1.31 | $1.31 | $1.4599 | $1.2894 | 147,731 | 10-01-2024 |
| $1.46 | $1.86 | $1.46 | $1.8799 | $1.34 | 487,504 | 09-30-2024 |
| $1.85 | $1.57 | $1.85 | $1.94 | $1.55 | 370,333 | 09-27-2024 |
| $1.54 | $1.5498 | $1.54 | $1.65 | $1.54 | 112,040 | 09-26-2024 |
| $1.54 | $1.53 | $1.54 | $1.5499 | $1.5 | 8,516 | 09-25-2024 |
| $1.53 | $1.6 | $1.53 | $1.6 | $1.5 | 50,477 | 09-24-2024 |
| $1.59 | $1.59 | $1.59 | $1.6025 | $1.53 | 14,365 | 09-23-2024 |
| $1.64 | $1.58 | $1.64 | $1.64 | $1.5023 | 34,696 | 09-20-2024 |
| $1.6 | $1.69 | $1.6 | $1.74 | $1.5 | 70,666 | 09-19-2024 |
| $1.62 | $1.6 | $1.62 | $1.76 | $1.6 | 81,790 | 09-18-2024 |
| $1.59 | $1.58 | $1.59 | $1.59 | $1.5101 | 26,211 | 09-17-2024 |
| $1.51 | $1.5 | $1.51 | $1.5645 | $1.46 | 18,490 | 09-16-2024 |
News, Short Squeeze, Breakout and More Instantly...
PLUS THERAPEUTICS Inc. Company Name:
PSTV Stock Symbol:
NASDAQ Market:
PLUS THERAPEUTICS Inc. Website:
Ad
-
Rhenium ( 186 Re) Obisbemeda delivered by convection enhanced delivery (CED) continues to show safety, response, and potential efficacy Mean Phase 2 absorbed dose was 300 Gy and 89% of patients exceeded the minimal dose threshold of 100 Gy ReSPECT-GBM Phase 1/2 trial...
-
A look at the top 10 most actives in the United States Kaixin Holdings (KXIN) rose 185.6% to $0.257 on volume of 221,326,351 shares NIO Inc. American depositary shares each representing one Class A (NIO) rose 13.8% to $7.4226 on volume of 58,343,558 shares NVIDIA Corporation (NVDA) fell 0.4...
-
2024-09-27 20:45:00 ET Recently, I hit a portfolio milestone: $3,800 in annual dividend and interest income. I hit this passive income level when I did my research for an article about my plan to hit $5,000 a year in passive income in 2025. As part of my research, I looked up my project...
Important Investor News Alert (OTC: AABB)
-
Vancouver, Kelowna, and Delta, British Columbia--(Newsfile Corp. - October 9, 2024) - Investorideas.com , a global investor news source covering mining and metals stocks releases a snapshot looking at recent news and updates with gold stocks featuring Asia Broadband Inc. (OTC: AABB), a resource ...